XML 72 R27.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
INCOME TAXES
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
INCOME TAXES

18.

INCOME TAXES:

The components of income before income taxes are as follows (in thousands):

 

 

 

Year ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

United States

 

$

53,629

 

 

$

13,565

 

 

$

100,260

 

Foreign

 

 

116,276

 

 

 

50,746

 

 

 

49,277

 

Income before income taxes

 

$

169,905

 

 

$

64,311

 

 

$

149,537

 

 

The components of the income tax expense are as follows (in thousands):

 

 

 

Year ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Current income tax expense:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

$

(20,108

)

 

$

(9,097

)

 

$

(5,817

)

State

 

 

(755

)

 

 

(511

)

 

 

(54

)

Foreign

 

 

(16,514

)

 

 

(8,677

)

 

 

(15,406

)

 

 

 

(37,377

)

 

 

(18,285

)

 

 

(21,277

)

Deferred income tax benefit (expense):

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

 

5,208

 

 

 

12,622

 

 

 

(24,425

)

State

 

 

1,054

 

 

 

611

 

 

 

(23

)

Foreign

 

 

(486

)

 

 

(419

)

 

 

73

 

 

 

 

5,776

 

 

 

12,814

 

 

 

(24,375

)

Income tax expense

 

$

(31,601

)

 

$

(5,471

)

 

$

(45,652

)

 

Reconciliation of the statutory U.S. federal tax rate to the Company's effective tax rate is as follows:

 

 

 

Year ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Statutory U.S. federal income tax rate

 

 

21.0

%

 

 

21.0

%

 

 

35.0

%

State income taxes, net of federal benefit

 

 

0.1

 

 

 

(0.2

)

 

 

 

Effect of foreign operations

 

 

(5.4

)

 

 

(4.7

)

 

 

(7.1

)

Accruals and reserves

 

 

(1.1

)

 

 

 

 

 

0.1

 

Nondeductible employee compensation

 

 

2.5

 

 

 

1.7

 

 

 

1.5

 

Research tax credits

 

 

(1.4

)

 

 

(2.7

)

 

 

(0.7

)

Change in valuation allowance

 

 

 

 

 

 

 

 

(4.1

)

Stock based compensation

 

 

(1.7

)

 

 

(2.7

)

 

 

(1.9

)

U.S. Tax Cuts and Jobs Act

 

 

 

 

 

(3.5

)

 

 

7.7

 

U.S. International Tax (Sub F, GILTI, FDII)

 

 

3.8

 

 

 

(1.2

)

 

 

 

Other

 

 

0.8

 

 

 

0.8

 

 

 

 

Effective tax rate

 

 

18.6

%

 

 

8.5

%

 

 

30.5

%

 

The following table summarizes Company tax loss and tax credit carry forwards for tax return purposes at December 31, 2019 (in thousands):

 

 

 

Related Tax Deduction

 

Tax Benefit

 

 

Expiration Date

Tax credit carry forwards:

 

 

 

 

 

 

 

 

State research tax credits

 

n/a

 

$

3,368

 

 

2026 to 2034

Total credit carry forwards

 

n/a

 

$

3,368

 

 

 

Significant components of the Company's net deferred tax assets and liabilities are as follows (in thousands):

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Deferred tax asset:

 

 

 

 

 

 

 

 

Capitalized technology license

 

$

560

 

 

$

553

 

Capitalized research expenditures

 

 

3,319

 

 

 

4,710

 

Accruals and reserves

 

 

4,130

 

 

 

2,890

 

Retirement plan

 

 

11,363

 

 

 

9,570

 

Deferred revenue

 

 

14,354

 

 

 

12,028

 

Tax credit carry forwards

 

 

3,997

 

 

 

2,895

 

Stock-based compensation

 

 

1,884

 

 

 

1,701

 

Other

 

 

1,682

 

 

 

47

 

 

 

 

41,289

 

 

 

34,394

 

Valuation allowance

 

 

(3,368

)

 

 

(2,893

)

Deferred tax assets

 

 

37,921

 

 

 

31,501

 

Deferred tax liability:

 

 

 

 

 

 

 

 

Accruals and reserves

 

 

(7,546

)

 

 

(7,124

)

Deferred tax liabilities

 

 

(7,546

)

 

 

(7,124

)

Net deferred tax assets

 

$

30,375

 

 

$

24,377

 

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent on the Company's ability to generate future taxable income to obtain benefit from the reversal of temporary differences, net operating loss carryforwards and tax credits. As part of its assessment, management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies. At this time there is no evidence to release the valuation allowance that relates to the New Jersey research and development credit.

On December 27, 2018, the Korean Supreme Court, citing prior cases, held that the applicable law and interpretation of the Korea-U.S. Tax Treaty were clear that only royalties paid with respect to Korean registered patents are Korean source income and subject to Korean withholding tax.  Based on this decision, the Company has decided to litigate the Korean withholding taxes paid or withheld on the 2018 and 2019 royalty payments and has engaged a leading Korean law firm which has advised that there is a more-likely-than-not chance of success. As a result, as of December 31, 2019 and 2018, the Company has recorded a long-term asset of $26.9 million and $13.6 million, respectively, representing the allocation of withholding to non-Korean patents and a long-term liability of $25.7 million and $7.7 million, respectively, for estimated amounts due to the U.S. Federal government based on the amendment of U.S. tax returns for lower withholding amounts.

With respect to the Korean withholding for the years 2011 through 2017, the Company has decided to continue the U.S.-Korean Mutual Agreement Procedure which was accepted by the Korean National Tax Service (KNTS) on September 15, 2017. The Company believes that it is more-likely-than-not that a favorable settlement will be reached resulting in a reduction of the Korean withholding taxes previously withheld since 2011. A long-term asset of $36.9 million for estimated refunds due from the Korean government, a long-term payable of $16.2 million for estimated amounts due to the U.S. Federal government based on amendment of prior year U.S. tax returns for the lower withholding amounts, and a reduction of deferred tax assets for foreign tax credits and R&D credits of $20.7 million has been recorded on the December 31, 2019 and 2018 Consolidated Balance Sheets for this matter.

On October 30, 2018, the KNTS concluded a tax audit with LG Display that included the licensing and royalty payments made to UDC Ireland during the years 2015 through 2017.  The KNTS questioned whether UDC Ireland was the beneficial owner of these payments and assessed UDC Ireland a charge of $13.2 million for withholding and interest for the three-year period. UDC Ireland has engaged a leading Korean law firm which believes it is more-likely-than-not that UDC Ireland has beneficial ownership of the underlining intellectual property. As a result, a petition has been filed with the Tax Tribunal.  Based on this authority, UDC Ireland has paid the assessment which is recorded as a long-term asset as of December 31, 2019 and 2018.

For the years ended December 31, 2019, 2018 and 2017, the Company has incurred Korean withholding tax of $14.9 million, $14.9 million and $17.6 million, respectively; which is currently being appealed based on the interpretation of the Korea-U.S. Tax Treaty and recent Korean Supreme Court decisions.

The Company’s 2013 federal income tax return was audited by the Internal Revenue Services with no change; the years 2016 to 2019 are open and subject to examination. The State of New Jersey is currently auditing the 2014 to 2017 tax returns of UDC Inc. The state and foreign tax returns are open for a period of generally three to four years.

The above estimates may change in the future and ultimately upon settlement of these uncertain tax positions.